Self-testing in Switzerland: what's allowed, where it's sold, and why prevention is moving to the pharmacy
Opinion and general information only, not legal, regulatory or medical advice. Please read the legal notice at the end.
Switzerland is moving prevention closer to people, and the pharmacy is becoming its front door. Rising costs push policymakers to shift simple care out of the doctor's practice, people say they want prevention at their pharmacy, and Swiss law ties self-tests to professional advice. For self-testing, this means the winning model in Switzerland is not "test alone at home" but "test at home, with an expert one step away".
The argument in brief
- Cost pressure is structural. Health spending reached CHF 97 billion in 2024, and basic insurance premiums rise by 5.0% in 2027.
- People want prevention nearby. Close to 60% of the population wants prevention services directly at the pharmacy.
- Policy is following. From 1 January 2027, pharmacists may give preventive vaccinations covered by basic insurance.
- The law already links self-tests to advice. A self-test may only be supplied where professional advice is guaranteed.
Together, these point to one conclusion: in Switzerland, self-testing grows through the pharmacy, not around it.
Why now
Swiss health costs rose 4.1% in 2024 to CHF 97 billion, or CHF 10,792 per person, and households paid 21.3% of that directly (FSO, via ZWP). In 2027 the average monthly premium for basic insurance rises 5.0% to CHF 412. The Federal Office of Public Health names more treatments, medical-technological progress and an ageing population as the main drivers (FOPH).
That leaves two levers: catch problems earlier, and handle simple care at lower-cost points of contact. Swiss people are open to both. According to pharmaSuisse, close to 60% want prevention services directly at the pharmacy (pharmaSuisse). And the Swiss eHealth Barometer 2026 finds that many people can imagine buying health products online, while acceptance rises markedly when the offer is checked or certified by public authorities (FMH, eHealth Barometer 2026).
The message is consistent: Swiss consumers will take more of their health into their own hands, but they want it to come with trust attached.
What is allowed
Self-tests are in vitro diagnostic medical devices, regulated by Swissmedic under the In Vitro Diagnostic Medical Devices Ordinance (IvDO). Three rules shape the market:
| Rule | What it says | What it means in practice |
|---|---|---|
| Professional advice | A self-test may only be supplied if the dispensing point can guarantee that professional advice is available (Art. 61 para. 2 IvDO) | Pharmacies and drugstores meet this naturally; online sellers must build advice into the service |
| Communicable diseases | Tests for diagnosing communicable diseases may not be supplied to the public, unless Swissmedic grants an exception in the interest of public health (Art. 61 para. 3 IvDO) | HIV self-tests have been allowed since 2018 (FOPH); other infection tests need a clear legal basis before launch |
| Three languages | Information for self-tests must be easy to understand and written in German, French and Italian (Art. 15 IvDO) | One pack for all of Switzerland, or none |
On top of these come the general rules for any device: a Swiss authorised representative, a Swiss importer, registration in swissdamed from 1 July 2026, and advertising that says nothing the product information does not.
Where self-tests are sold
Each channel answers the advice requirement differently, and that shapes who wins in it.
| Channel | How advice is provided | Strength | Limit |
|---|---|---|---|
| Pharmacies | Pharmacist at the counter | Highest trust; 1,830 locations | Shelf space and margins are competitive |
| Drugstores | Trained drugstore staff | Strong in self-care and prevention categories | Smaller network, fewer chains |
| Online shops and marketplaces | Must be designed in: a pharmacist service, hotline or structured guidance | Reach, convenience, discretion | Advice and trust must be proven, not assumed |
| Brand webshop | Same as online, under the brand's own control | Data, relationship, subscriptions | Shipping costs make single low-priced tests hard to sell profitably |
The most robust Swiss models combine them: online for discovery, convenience and repeat purchase, the pharmacy for advice and a follow-up when a result needs action.
Why the pharmacy is becoming the front door of prevention
Three developments are converging.
Policy is widening the pharmacist's role. From 1 January 2027, pharmacists may give preventive vaccinations, with the vaccination and the counselling covered by basic insurance. The announcement presents this as strengthening pharmacists' role in primary care (FOPH, 11 June 2026).
The network is scarce, so each pharmacy matters more. Switzerland has about 20 pharmacies per 100,000 inhabitants, against a European average of about 31 (pharmaSuisse). Pharmacies that already advise, test and vaccinate are natural hubs for prevention.
Self-testing needs a place to land. A home test produces a number or a line. The value comes from what happens next: understanding the result, deciding whether to see a doctor, adjusting habits. In Switzerland, that next step most naturally happens at the pharmacy, the same place the law expects advice to come from.
The result is a prevention loop: test at home, understand it with a professional, act, and test again.
What this means for health brands entering Switzerland
For a self-testing or prevention brand, five choices follow from this.
- Design for the pharmacist, not only the consumer. Training material, a clear "what to do with your result" guide and a reason for the pharmacist to recommend you. In Switzerland, the pharmacist is part of your product.
- Build advice into every online sale. If you sell online, decide from day one how professional advice is guaranteed, for example through a pharmacist partner or a structured advice service.
- Check the legal status of every test first. Tests for communicable diseases face a ban on public supply unless an exception applies. Know where each test stands before you commit stock and packaging.
- Launch with one Swiss pack in three languages. It is a legal requirement for self-tests, and it is how you reach Romandie and Ticino from the start.
- Earn trust with restraint. Claims that match the instructions for use, visible Swiss registration and a Swiss partner who answers for the product carry more weight here than bold promises.
The brands that will lead Swiss self-testing are the ones that treat the pharmacy as their partner and trust as their product.
About 11Alto
11Alto is a Zürich-based market-entry platform for international health companies. We help brands bring self-tests and other health products to Switzerland the right way: regulated, in three languages and through the channels Swiss people trust. Write to info@11alto.com or use the contact form.
Legal notice
Opinion and general information only. This perspective expresses the views of 11Alto AG, based on publicly available sources as of November 2026, and is not updated automatically. It is not legal, regulatory, medical or other professional advice, and it does not replace an assessment of a specific product by a qualified adviser or the competent authority.
Not medical advice. Nothing in this perspective is a recommendation to use any test or product. Self-tests do not replace a medical diagnosis; results should be discussed with a doctor or pharmacist. In an emergency, call 144.
Commercial interest. 11Alto AG represents and distributes health brands in Switzerland, including self-testing products, in some cases on an exclusive basis, and may benefit commercially from the developments described here.
No warranty, limited liability. 11Alto AG has prepared this perspective with care but gives no warranty, express or implied, that it is complete, accurate or current. To the fullest extent permitted by law, 11Alto AG and its directors, employees and partners accept no liability for any direct or indirect loss arising from the use of, or reliance on, this perspective.
Check before acting. Laws, regulations and authority practice change, and how they apply depends on each product and case. Confirm the current requirements with Swissmedic or another competent authority before taking any decision. Third-party figures, names and trademarks are cited from their public sources and remain the property of their owners. 11Alto AG is not responsible for the content of linked websites.
Applicable law. This notice is governed by Swiss law. The place of jurisdiction is Zürich, Switzerland.
Sources
- FSO health cost figures 2024, reported by ZWP online (27 April 2026)
- FOPH: 2027 health insurance premiums (29 September 2026)
- FOPH: pharmacists may vaccinate from 1 January 2027 (11 June 2026)
- pharmaSuisse, Facts & Figures 2025
- FMH, Swiss eHealth Barometer 2026 press release
- FOPH: HIV self-tests
- IvDO Art. 61 (supply to the public) and Art. 15 (product information)